Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112538574 | 11253857 | 4 | F | 20160919 | 20150709 | 20160927 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-045018 | BRISTOL MYERS SQUIBB | 57.00 | YR | M | Y | 0.00000 | 20160927 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112538574 | 11253857 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG, UNK | Y | 21436 | 5 | MG | TABLET | ||||||
| 112538574 | 11253857 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 1.25 MG, UNK | Y | 21436 | 1.25 | MG | TABLET | ||||||
| 112538574 | 11253857 | 3 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 1.25 MG, QD | U | 0 | 1.25 | MG | QD | ||||||
| 112538574 | 11253857 | 4 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 0 | |||||||||||
| 112538574 | 11253857 | 5 | C | VIIBRYD | VILAZODONE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112538574 | 11253857 | 1 | Major depression |
| 112538574 | 11253857 | 2 | Generalised anxiety disorder |
| 112538574 | 11253857 | 3 | Major depression |
| 112538574 | 11253857 | 4 | Generalised anxiety disorder |
| 112538574 | 11253857 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112538574 | 11253857 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112538574 | 11253857 | Dyspnoea | |
| 112538574 | 11253857 | Fatigue | |
| 112538574 | 11253857 | Hepatic enzyme increased | |
| 112538574 | 11253857 | Hepatic steatosis | |
| 112538574 | 11253857 | Muscle twitching | |
| 112538574 | 11253857 | Platelet count decreased | |
| 112538574 | 11253857 | Underdose | |
| 112538574 | 11253857 | Weight increased | |
| 112538574 | 11253857 | White blood cell count decreased | |
| 112538574 | 11253857 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112538574 | 11253857 | 1 | 201506 | 0 | ||
| 112538574 | 11253857 | 2 | 20151208 | 0 | ||
| 112538574 | 11253857 | 3 | 20151208 | 0 |